Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
184.8 DKK | +4.14% | +2.69% | +4.17% |
May. 31 | Bavarian Nordic Files for Supplemental US License for Smallpox-Monkeypox Vaccine | MT |
May. 30 | Bavarian Nordic Gets $6.5 Million Funding for Development of Mpox Vaccine in Children | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.17% | 2.09B | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- BAVA Stock
- News Bavarian Nordic A/S
- Transcript : Bavarian Nordic A/S, Q1 2024 Earnings Call, May 08, 2024